<?xml version="1.0" encoding="UTF-8"?>
<ref id="R79">
 <label>79.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Razonable</surname>
    <given-names>RR</given-names>
   </name>
   <name>
    <surname>Paya</surname>
    <given-names>CV</given-names>
   </name>
  </person-group>
  <article-title>Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts</article-title>. 
  <source>
   <italic>Expert Rev Anti Infect Ther</italic>
  </source>. 
  <year>2004</year>;
  <volume>2</volume>:
  <fpage>27</fpage>-
  <lpage>41</lpage>
  <pub-id pub-id-type="pmid">15482169</pub-id>
 </mixed-citation>
</ref>
